Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 380 (LINC00380) is a long intergenic non-coding RNA (lincRNA), classified as a type of long non-coding RNA (lncRNA) that is transcribed from regions of the genome not overlapping protein-coding genes[1][3][5]. LincRNAs such as LINC00380 generally function in regulating gene expression through diverse mechanisms including chromatin remodeling, transcriptional regulation, and stabilization of other RNAs[2][4][6]. LINC00380 is annotated in the human genome and has aliases including TCONS_00021685, but there is currently no evidence or literature supporting its role as a direct therapeutic target, biomarker, or being clinically actionable. Its specific biological role and disease associations remain uncharacterized as of present data[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 380 (LINC00380).